These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role and fate of PML nuclear bodies in response to interferon and viral infections. Regad T, Chelbi-Alix MK. Oncogene; 2001 Oct 29; 20(49):7274-86. PubMed ID: 11704856 [Abstract] [Full Text] [Related]
3. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML. Engelhardt OG, Boutell C, Orr A, Ullrich E, Haller O, Everett RD. Exp Cell Res; 2003 Feb 01; 283(1):36-50. PubMed ID: 12565818 [Abstract] [Full Text] [Related]
5. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. Meinecke I, Cinski A, Baier A, Peters MA, Dankbar B, Wille A, Drynda A, Mendoza H, Gay RE, Hay RT, Ink B, Gay S, Pap T. Proc Natl Acad Sci U S A; 2007 Mar 20; 104(12):5073-8. PubMed ID: 17360386 [Abstract] [Full Text] [Related]
8. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, Yeh ET, Strauss JF, Maul GG. J Cell Biol; 1999 Oct 18; 147(2):221-34. PubMed ID: 10525530 [Abstract] [Full Text] [Related]
10. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. Sternsdorf T, Jensen K, Will H. J Cell Biol; 1997 Dec 29; 139(7):1621-34. PubMed ID: 9412458 [Abstract] [Full Text] [Related]
11. Role of SUMO-1-modified PML in nuclear body formation. Zhong S, Müller S, Ronchetti S, Freemont PS, Dejean A, Pandolfi PP. Blood; 2000 May 01; 95(9):2748-52. PubMed ID: 10779416 [Abstract] [Full Text] [Related]
12. Death-domain associated protein-6 (DAXX) mediated apoptosis in hantavirus infection is counter-balanced by activation of interferon-stimulated nuclear transcription factors. Khaiboullina SF, Morzunov SP, Boichuk SV, Palotás A, St Jeor S, Lombardi VC, Rizvanov AA. Virology; 2013 Sep 01; 443(2):338-48. PubMed ID: 23830076 [Abstract] [Full Text] [Related]
13. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML. Lehembre F, Müller S, Pandolfi PP, Dejean A. Oncogene; 2001 Jan 04; 20(1):1-9. PubMed ID: 11244500 [Abstract] [Full Text] [Related]
18. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Fu C, Ahmed K, Ding H, Ding X, Lan J, Yang Z, Miao Y, Zhu Y, Shi Y, Zhu J, Huang H, Yao X. Oncogene; 2005 Aug 18; 24(35):5401-13. PubMed ID: 15940266 [Abstract] [Full Text] [Related]